The First AI Test That Predicts Breast Cancer Risk From a Pathology Slide Just Cleared the FDA
ArteraAI Breast has become the first FDA-cleared AI digital-pathology risk test for breast cancer, giving doctors a new way to estimate how aggressively a tumor is likely to behave directly from pathology images.